BOTWOOD NICHOLAS A.J. (Head of R&D, CMO) received a stock award from SYNDAX PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/6/2026ACC: 0001193125-26-041334
Officer· Head of R&D, CMO
Since Feb 2026
+204.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
204.70K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24K
Price / share
—
Trade value
—
% of position
68.2%
2/4/2026
35.16K→59.16K
Common Stock
Direct
Shares
+36K
Price / share
—
Trade value
—
% of position
60.8%
2/4/2026
59.16K→95.17K
Total
Net shares
+60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | A · Award | +24K | — | — | 68.2% | 35.16K | 59.16K |
| Common Stock Direct | 2/4/2026 | A · Award | +36K | — | — | 60.8% | 59.16K | 95.17K |
| Total | +60K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
144.70K shares
Shares
+144.70K
Strike price
20.43
Held after
144.70K
Exercisable
—
2/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock144.70K shares | 2/4/2026 | A · Award | +144.70K | 20.43 | — | 144.70K |